Exaluren
EL-017
Phase 2 small_molecule active
Quick answer
Exaluren for Alport Syndrome, X-Linked is a Phase 2 program (small_molecule) at Eloxx Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Eloxx Pharmaceuticals
- Indication
- Alport Syndrome, X-Linked
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active